Screener
Simulations Plus SLP Medical Communications — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Simulations Plus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Simulations Plus’s 10-K, filed December 1, 2025.
- Filed
- Dec 1, 2025
- Fiscal year
- FY2025
- Accession
- 0001023459-25-000060
| (in thousands, except per common share amounts) | Years ended August 31, 2025 | Years ended August 31, 2024 | Years ended August 31, 2023 |
|---|---|---|---|
| Revenues | |||
| Software | $45,828 | $41,024 | $36,517 |
| Services | 33,351 | 28,989 | 23,060 |
| Total revenues | 79,179 | 70,013 | 59,577 |
| Cost of revenues | |||
| Software | 9,652 | 6,478 | 3,627 |
| Services | 23,306 | 20,384 | 8,003 |
| Total cost of revenues | 32,958 | 26,862 | 11,630 |
Item 15. – EXHIBITS, FINANCIAL STATEMENT SCHEDULES
FAQ
- What is Simulations Plus's medical communications — revenue?
- Simulations Plus (SLP) reported medical communications — revenue of $2.03M in Q2 2025.
- How has Simulations Plus's medical communications — revenue changed year-over-year?
- Simulations Plus's medical communications — revenue increased by 622.1% year-over-year, from $281K to $2.03M.
- What does medical communications — revenue mean?
- This metric represents the total gross revenue generated from specialized medical communications services provided to pharmaceutical and biotechnology clients. It reflects the company's ability to monetize scientific content dissemination and strategic communication support within its service portfolio. Growth in this segment indicates successful expansion into non-software service offerings and deeper integration into the drug development lifecycle.
Ask your AI about Simulations Plus's medical communications — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude